 Rachel McMahan
Concepts (268)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Burns | 8 | 2025 | 289 | 1.810 |
Why?
| | Gastrointestinal Microbiome | 6 | 2025 | 637 | 1.530 |
Why?
| | Ethanol | 9 | 2024 | 578 | 1.210 |
Why?
| | Dysbiosis | 5 | 2025 | 166 | 1.200 |
Why?
| | Feces | 3 | 2025 | 434 | 1.000 |
Why?
| | Intestines | 3 | 2022 | 347 | 0.900 |
Why?
| | Public Opinion | 2 | 2023 | 65 | 0.860 |
Why?
| | Pneumonia | 3 | 2025 | 613 | 0.840 |
Why?
| | Inflammation | 8 | 2024 | 2705 | 0.790 |
Why?
| | Hepacivirus | 5 | 2017 | 237 | 0.610 |
Why?
| | Alcohol Drinking | 3 | 2024 | 744 | 0.610 |
Why?
| | Receptors, Antigen, T-Cell | 6 | 2017 | 699 | 0.600 |
Why?
| | Non-alcoholic Fatty Liver Disease | 5 | 2020 | 256 | 0.570 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2024 | 544 | 0.570 |
Why?
| | Liver | 7 | 2024 | 1848 | 0.560 |
Why?
| | Alcoholism | 5 | 2024 | 760 | 0.520 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2016 | 211 | 0.490 |
Why?
| | Mice | 26 | 2025 | 16585 | 0.460 |
Why?
| | T-Lymphocytes | 7 | 2017 | 1911 | 0.450 |
Why?
| | Fatty Liver | 2 | 2013 | 230 | 0.440 |
Why?
| | Mice, Inbred C57BL | 13 | 2025 | 5279 | 0.430 |
Why?
| | T-Lymphocytes, Cytotoxic | 2 | 2010 | 166 | 0.400 |
Why?
| | Macrophages | 8 | 2024 | 1459 | 0.390 |
Why?
| | Hepatitis C, Chronic | 2 | 2011 | 156 | 0.390 |
Why?
| | Alcoholic Intoxication | 2 | 2023 | 64 | 0.390 |
Why?
| | Cancer Vaccines | 3 | 2010 | 164 | 0.380 |
Why?
| | Epitopes, T-Lymphocyte | 2 | 2016 | 186 | 0.370 |
Why?
| | Monocytes | 3 | 2013 | 554 | 0.370 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2013 | 199 | 0.370 |
Why?
| | Animals | 30 | 2025 | 34733 | 0.360 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2010 | 181 | 0.330 |
Why?
| | Age Factors | 4 | 2025 | 3145 | 0.310 |
Why?
| | Major Histocompatibility Complex | 3 | 2017 | 228 | 0.300 |
Why?
| | Antigens, CD | 1 | 2010 | 479 | 0.300 |
Why?
| | Lymphocyte Activation | 4 | 2007 | 1095 | 0.290 |
Why?
| | Permeability | 3 | 2022 | 158 | 0.290 |
Why?
| | Disease Models, Animal | 9 | 2025 | 4016 | 0.280 |
Why?
| | Macrophages, Alveolar | 3 | 2022 | 389 | 0.280 |
Why?
| | Myelin Basic Protein | 2 | 2003 | 46 | 0.260 |
Why?
| | Histocompatibility Antigens Class II | 2 | 2024 | 360 | 0.260 |
Why?
| | Membrane Proteins | 2 | 2013 | 1108 | 0.240 |
Why?
| | Kupffer Cells | 2 | 2019 | 51 | 0.240 |
Why?
| | Immunity, Innate | 2 | 2024 | 806 | 0.240 |
Why?
| | Azepines | 1 | 2024 | 87 | 0.230 |
Why?
| | Glycerophospholipids | 1 | 2024 | 32 | 0.220 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2024 | 52 | 0.220 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2024 | 126 | 0.220 |
Why?
| | Diet, Western | 1 | 2024 | 80 | 0.220 |
Why?
| | Graft Rejection | 1 | 2007 | 569 | 0.210 |
Why?
| | Binge Drinking | 1 | 2023 | 34 | 0.210 |
Why?
| | Triazoles | 1 | 2024 | 153 | 0.210 |
Why?
| | Hawaii | 1 | 2023 | 41 | 0.210 |
Why?
| | Tryptophan | 1 | 2024 | 166 | 0.210 |
Why?
| | Respiratory Function Tests | 1 | 2025 | 594 | 0.200 |
Why?
| | alpha-Defensins | 1 | 2022 | 11 | 0.200 |
Why?
| | Cytotoxicity, Immunologic | 4 | 2013 | 214 | 0.200 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2022 | 41 | 0.190 |
Why?
| | Delirium | 1 | 2023 | 77 | 0.190 |
Why?
| | Galectins | 2 | 2013 | 22 | 0.190 |
Why?
| | Tight Junctions | 1 | 2021 | 74 | 0.180 |
Why?
| | Lung | 5 | 2024 | 3928 | 0.180 |
Why?
| | Intestinal Mucosa | 3 | 2021 | 569 | 0.180 |
Why?
| | Pneumococcal Infections | 1 | 2022 | 111 | 0.180 |
Why?
| | Cell Cycle Proteins | 1 | 2024 | 577 | 0.180 |
Why?
| | Astrocytes | 1 | 2022 | 186 | 0.180 |
Why?
| | Hepatitis C | 2 | 2016 | 235 | 0.170 |
Why?
| | Diet, High-Fat | 3 | 2020 | 241 | 0.170 |
Why?
| | Cytokines | 4 | 2023 | 2008 | 0.170 |
Why?
| | Nuclear Proteins | 1 | 2024 | 644 | 0.170 |
Why?
| | Boston | 1 | 2020 | 90 | 0.170 |
Why?
| | Lipoproteins, LDL | 1 | 2020 | 131 | 0.170 |
Why?
| | Lymphatic Vessels | 1 | 2020 | 59 | 0.170 |
Why?
| | Glomerulonephritis | 2 | 2018 | 46 | 0.170 |
Why?
| | Myocardium | 1 | 2024 | 982 | 0.160 |
Why?
| | Cholesterol, Dietary | 1 | 2019 | 18 | 0.160 |
Why?
| | Liver Cirrhosis, Experimental | 1 | 2019 | 11 | 0.160 |
Why?
| | Perilipin-2 | 1 | 2019 | 36 | 0.160 |
Why?
| | Humans | 25 | 2024 | 129705 | 0.150 |
Why?
| | Male | 16 | 2025 | 63544 | 0.150 |
Why?
| | Congresses as Topic | 1 | 2020 | 217 | 0.150 |
Why?
| | Gastrointestinal Tract | 1 | 2020 | 182 | 0.150 |
Why?
| | Osteopontin | 1 | 2018 | 32 | 0.150 |
Why?
| | Liver Diseases | 1 | 2021 | 290 | 0.150 |
Why?
| | Hepatocytes | 1 | 2019 | 217 | 0.140 |
Why?
| | Kidney Glomerulus | 1 | 2018 | 106 | 0.140 |
Why?
| | Myocardial Infarction | 1 | 2024 | 1032 | 0.140 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1208 | 0.140 |
Why?
| | Interleukin-10 | 2 | 2024 | 299 | 0.140 |
Why?
| | Sevelamer | 1 | 2016 | 9 | 0.140 |
Why?
| | Histocompatibility Antigens Class I | 2 | 2016 | 196 | 0.130 |
Why?
| | Immunotherapy | 3 | 2017 | 581 | 0.130 |
Why?
| | Transcription Factors | 1 | 2024 | 1636 | 0.130 |
Why?
| | Receptor, Adenosine A2A | 1 | 2016 | 20 | 0.130 |
Why?
| | Adenosine A2 Receptor Agonists | 1 | 2016 | 20 | 0.130 |
Why?
| | Antigens, Neoplasm | 2 | 2010 | 308 | 0.130 |
Why?
| | Mice, Inbred BALB C | 4 | 2010 | 1241 | 0.130 |
Why?
| | Neoplasms | 2 | 2008 | 2435 | 0.130 |
Why?
| | Genomic Instability | 1 | 2016 | 47 | 0.130 |
Why?
| | Microbiota | 1 | 2023 | 727 | 0.120 |
Why?
| | Hepatitis A Virus Cellular Receptor 2 | 2 | 2013 | 30 | 0.120 |
Why?
| | Pregnancy | 2 | 2024 | 6273 | 0.110 |
Why?
| | Fructokinases | 1 | 2013 | 30 | 0.110 |
Why?
| | Ligands | 3 | 2023 | 615 | 0.110 |
Why?
| | Mice, Knockout | 5 | 2024 | 2778 | 0.110 |
Why?
| | Sucrose | 1 | 2013 | 93 | 0.110 |
Why?
| | Mannose-Binding Lectins | 1 | 2013 | 12 | 0.110 |
Why?
| | Mice, Obese | 1 | 2013 | 55 | 0.100 |
Why?
| | Lectins, C-Type | 1 | 2013 | 69 | 0.100 |
Why?
| | Antibodies, Blocking | 2 | 2010 | 33 | 0.100 |
Why?
| | Anti-Inflammatory Agents | 1 | 2016 | 471 | 0.100 |
Why?
| | Biomarkers | 2 | 2024 | 3893 | 0.100 |
Why?
| | Cyclic AMP | 1 | 2013 | 231 | 0.100 |
Why?
| | Female | 11 | 2024 | 68561 | 0.100 |
Why?
| | Macrophage Activation | 1 | 2013 | 178 | 0.100 |
Why?
| | Herpesviridae Infections | 1 | 2013 | 142 | 0.090 |
Why?
| | Chemokines | 2 | 2023 | 230 | 0.090 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2013 | 377 | 0.090 |
Why?
| | Receptors, Cell Surface | 1 | 2013 | 379 | 0.090 |
Why?
| | Conserved Sequence | 1 | 2011 | 229 | 0.090 |
Why?
| | Genome, Viral | 1 | 2011 | 131 | 0.090 |
Why?
| | Peptide Library | 2 | 2010 | 87 | 0.090 |
Why?
| | Aging | 3 | 2024 | 1769 | 0.090 |
Why?
| | Vaccines, Subunit | 1 | 2010 | 47 | 0.080 |
Why?
| | Killer Cells, Natural | 1 | 2013 | 422 | 0.080 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2010 | 91 | 0.080 |
Why?
| | In Vitro Techniques | 1 | 2010 | 1063 | 0.080 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2010 | 227 | 0.080 |
Why?
| | Viral Proteins | 1 | 2011 | 330 | 0.080 |
Why?
| | Kidney | 2 | 2016 | 1330 | 0.080 |
Why?
| | Ischemia | 1 | 2011 | 396 | 0.080 |
Why?
| | T-Lymphocyte Subsets | 1 | 2010 | 413 | 0.070 |
Why?
| | Amino Acid Sequence | 3 | 2017 | 2051 | 0.070 |
Why?
| | Baculoviridae | 1 | 2008 | 44 | 0.070 |
Why?
| | Cloning, Molecular | 3 | 2004 | 536 | 0.070 |
Why?
| | H-2 Antigens | 1 | 2008 | 114 | 0.070 |
Why?
| | Insecta | 1 | 2008 | 68 | 0.070 |
Why?
| | Up-Regulation | 1 | 2010 | 850 | 0.070 |
Why?
| | Cross Reactions | 2 | 2017 | 130 | 0.070 |
Why?
| | Rats, Inbred Lew | 2 | 2003 | 91 | 0.060 |
Why?
| | Genetic Variation | 1 | 2011 | 936 | 0.060 |
Why?
| | Colonic Neoplasms | 1 | 2008 | 234 | 0.060 |
Why?
| | Immune Tolerance | 1 | 2008 | 348 | 0.060 |
Why?
| | Drug Design | 1 | 2006 | 157 | 0.060 |
Why?
| | Obesity | 1 | 2019 | 2851 | 0.060 |
Why?
| | DNA Primers | 1 | 2006 | 523 | 0.060 |
Why?
| | Bacteroidetes | 1 | 2024 | 23 | 0.060 |
Why?
| | Interleukin-6 | 2 | 2023 | 715 | 0.060 |
Why?
| | Fecal Microbiota Transplantation | 1 | 2024 | 18 | 0.060 |
Why?
| | Receptors, Interleukin-2 | 1 | 2004 | 65 | 0.060 |
Why?
| | Signal Transduction | 3 | 2024 | 4863 | 0.060 |
Why?
| | Ileum | 1 | 2024 | 113 | 0.060 |
Why?
| | Acute Kidney Injury | 1 | 2011 | 787 | 0.060 |
Why?
| | Fatty Acids, Volatile | 1 | 2024 | 57 | 0.050 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2522 | 0.050 |
Why?
| | Recombinant Proteins | 2 | 2004 | 1306 | 0.050 |
Why?
| | Cell Proliferation | 1 | 2010 | 2340 | 0.050 |
Why?
| | Case-Control Studies | 1 | 2010 | 3363 | 0.050 |
Why?
| | Solubility | 1 | 2003 | 234 | 0.050 |
Why?
| | Body Surface Area | 1 | 2022 | 34 | 0.050 |
Why?
| | Aged | 3 | 2023 | 22113 | 0.050 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2024 | 168 | 0.050 |
Why?
| | Colorectal Neoplasms | 1 | 2010 | 731 | 0.050 |
Why?
| | Burn Units | 1 | 2022 | 42 | 0.050 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2010 | 1049 | 0.050 |
Why?
| | Cells, Cultured | 2 | 2024 | 4058 | 0.050 |
Why?
| | Occludin | 1 | 2021 | 11 | 0.050 |
Why?
| | Fibroblasts | 2 | 2024 | 946 | 0.050 |
Why?
| | Liver Cirrhosis | 1 | 2023 | 278 | 0.050 |
Why?
| | Autoimmunity | 1 | 2007 | 869 | 0.050 |
Why?
| | Colon | 1 | 2023 | 247 | 0.050 |
Why?
| | Malondialdehyde | 1 | 2021 | 28 | 0.050 |
Why?
| | Young Adult | 2 | 2024 | 12363 | 0.050 |
Why?
| | Molecular Sequence Data | 2 | 2003 | 2848 | 0.050 |
Why?
| | Cell Line | 3 | 2017 | 2768 | 0.040 |
Why?
| | Aspartate Aminotransferases | 1 | 2021 | 89 | 0.040 |
Why?
| | Lipid Peroxidation | 1 | 2021 | 147 | 0.040 |
Why?
| | Protein Structure, Tertiary | 1 | 2003 | 833 | 0.040 |
Why?
| | Intercellular Junctions | 1 | 2020 | 39 | 0.040 |
Why?
| | Middle Aged | 3 | 2024 | 31103 | 0.040 |
Why?
| | NF-kappa B | 1 | 2024 | 687 | 0.040 |
Why?
| | Streptococcus pneumoniae | 1 | 2022 | 159 | 0.040 |
Why?
| | Proteostasis | 1 | 2020 | 26 | 0.040 |
Why?
| | Alanine Transaminase | 1 | 2021 | 149 | 0.040 |
Why?
| | Mice, Transgenic | 3 | 2011 | 2075 | 0.040 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2001 | 59 | 0.040 |
Why?
| | Histocompatibility Antigens | 1 | 2001 | 109 | 0.040 |
Why?
| | Epitopes | 2 | 2017 | 468 | 0.040 |
Why?
| | Interferon-gamma | 3 | 2010 | 765 | 0.040 |
Why?
| | Organ Specificity | 1 | 2020 | 296 | 0.040 |
Why?
| | Antigen Presentation | 1 | 2001 | 205 | 0.040 |
Why?
| | Glutathione | 1 | 2021 | 333 | 0.040 |
Why?
| | Escherichia coli | 1 | 2003 | 790 | 0.040 |
Why?
| | Multivariate Analysis | 1 | 2023 | 1507 | 0.040 |
Why?
| | Aged, 80 and over | 1 | 2010 | 7074 | 0.040 |
Why?
| | Hepatitis | 1 | 2019 | 49 | 0.040 |
Why?
| | Tumor Suppressor Proteins | 1 | 2020 | 314 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 265 | 0.040 |
Why?
| | Gene Expression | 1 | 2003 | 1477 | 0.040 |
Why?
| | Urinary Tract | 1 | 2018 | 37 | 0.040 |
Why?
| | Peptides | 2 | 2017 | 903 | 0.040 |
Why?
| | Hippocampus | 1 | 2022 | 786 | 0.040 |
Why?
| | Isoantigens | 1 | 2017 | 14 | 0.040 |
Why?
| | Rats | 2 | 2003 | 5244 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2022 | 614 | 0.040 |
Why?
| | HLA-A2 Antigen | 1 | 2017 | 48 | 0.040 |
Why?
| | Molecular Mimicry | 1 | 2017 | 38 | 0.040 |
Why?
| | Adult | 3 | 2024 | 35595 | 0.030 |
Why?
| | Jurkat Cells | 1 | 2017 | 136 | 0.030 |
Why?
| | Homeodomain Proteins | 1 | 2020 | 480 | 0.030 |
Why?
| | Viral Nonstructural Proteins | 1 | 2017 | 58 | 0.030 |
Why?
| | Bacteria | 1 | 2023 | 813 | 0.030 |
Why?
| | Homeostasis | 1 | 2020 | 604 | 0.030 |
Why?
| | Glomerular Basement Membrane | 1 | 2016 | 7 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2016 | 832 | 0.030 |
Why?
| | Neutrophils | 1 | 2022 | 1205 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2003 | 1360 | 0.030 |
Why?
| | Phenotype | 1 | 2024 | 3063 | 0.030 |
Why?
| | Protein Domains | 1 | 2017 | 244 | 0.030 |
Why?
| | Crystallography, X-Ray | 1 | 2017 | 436 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2019 | 491 | 0.030 |
Why?
| | Cognition | 1 | 2023 | 1098 | 0.030 |
Why?
| | Antigens, Viral | 1 | 2016 | 181 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2023 | 14669 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2019 | 588 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2017 | 673 | 0.030 |
Why?
| | Glucose | 1 | 2019 | 977 | 0.030 |
Why?
| | Muromegalovirus | 1 | 2013 | 14 | 0.030 |
Why?
| | Fructose | 1 | 2013 | 103 | 0.030 |
Why?
| | Transcriptome | 1 | 2019 | 872 | 0.030 |
Why?
| | Receptors, Virus | 1 | 2013 | 81 | 0.030 |
Why?
| | Interleukin-15 | 1 | 2013 | 82 | 0.030 |
Why?
| | Interleukin-12 | 1 | 2013 | 119 | 0.020 |
Why?
| | Models, Molecular | 1 | 2017 | 1480 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2612 | 0.020 |
Why?
| | Entropy | 1 | 2011 | 38 | 0.020 |
Why?
| | Genes, Viral | 1 | 2011 | 94 | 0.020 |
Why?
| | Energy Intake | 1 | 2013 | 460 | 0.020 |
Why?
| | Nucleotides | 1 | 2011 | 118 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2019 | 1165 | 0.020 |
Why?
| | Interleukin-7 Receptor alpha Subunit | 1 | 2010 | 12 | 0.020 |
Why?
| | Vaccination | 2 | 2010 | 1362 | 0.020 |
Why?
| | Spodoptera | 1 | 2010 | 37 | 0.020 |
Why?
| | Immunodominant Epitopes | 1 | 2010 | 28 | 0.020 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2010 | 77 | 0.020 |
Why?
| | Weight Gain | 1 | 2013 | 505 | 0.020 |
Why?
| | CD4 Antigens | 1 | 2010 | 137 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2010 | 182 | 0.020 |
Why?
| | Histocompatibility Antigen H-2D | 1 | 2008 | 21 | 0.020 |
Why?
| | Cross-Priming | 1 | 2008 | 18 | 0.020 |
Why?
| | CD11c Antigen | 1 | 2008 | 40 | 0.020 |
Why?
| | Amino Acids | 1 | 2011 | 470 | 0.020 |
Why?
| | RNA, Viral | 1 | 2011 | 622 | 0.020 |
Why?
| | Base Sequence | 1 | 2011 | 2161 | 0.020 |
Why?
| | Leukocytes, Mononuclear | 1 | 2010 | 543 | 0.020 |
Why?
| | Chronic Disease | 1 | 2011 | 1721 | 0.010 |
Why?
| | Silver Staining | 1 | 2004 | 17 | 0.010 |
Why?
| | Dendritic Cells | 1 | 2008 | 479 | 0.010 |
Why?
| | Genes, MHC Class II | 1 | 2004 | 72 | 0.010 |
Why?
| | Coculture Techniques | 1 | 2004 | 217 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2010 | 3106 | 0.010 |
Why?
| | Cell Lineage | 1 | 2004 | 333 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 962 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 828 | 0.010 |
Why?
| | Time Factors | 1 | 2011 | 6593 | 0.010 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2001 | 152 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2004 | 1151 | 0.010 |
Why?
| | Transfection | 1 | 2001 | 904 | 0.010 |
Why?
| | Adolescent | 1 | 2011 | 20355 | 0.010 |
Why?
|
|
McMahan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|